Inclusion Criteria:  Female participants capable of giving informed consent, or if appropriate, participants having an acceptable individual capable of giving consent on the participant's behalf Post-menopausal. Treatment with breast conserving surgery. Intended adjuvant whole breast radiotherapy dose to a dose of 40-42.5 Gy in 15-16 fractions. Luminal A subtype as determined by clinipathologic factors (ER/PR positive, Her-2 negative, low Ki-67 or low OncotypeDx recurrence score  Exclusion Criteria:  Women who have smoked within the last 5 years Patients requiring adjuvant chemotherapy. Requirement for regional nodal radiotherapy. Requirement for tumour bed boost. Breast implants Patients to be treated with partial breast irradiation.